TRIPLEWAX TYRE SHINE

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16

Adverse physicochemical, human health and environmental effects

May cause an allergic skin reaction

2.2 Label elements

Labelling according to GB CLP (SI 2019:720 as amended)

Hazard pictograms

GHS07

Signal word

(GHS UK) Warning

Contains

2-METHYLISOTHIAZOL-3(2H)-ONE

Hazard statements

H317 - May cause an allergic skin reaction.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P261 - Avoid breathing vapours, spray. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P333+P313 - If skin irritation or rash occurs: Get medical advice or attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents and container to a hazardous or special waste collection point, in accordance with local, regional, national and international regulations. Child-resistant fastening Not applicable Tactile warning Not applicable

Results of PBT and vPvB assessment

Component Substance(s) not meeting the PBT criteria of UK GLYCEROL (56-81-5), ETHANOL (64-17-5), 1,2-BENZISOTHIAZOL-3(2H)-ONE (2634- REACH regulation, in accordance with Annex XIII 33-5), 2-METHYLISOTHIAZOL-3(2H)-ONE (2682-20-4) Substance(s) not meeting the vPvB criteria of UK GLYCEROL (56-81-5), ETHANOL (64-17-5), 1,2-BENZISOTHIAZOL-3(2H)-ONE (2634- REACH regulation, in accordance with Annex XIII 33-5), 2-METHYLISOTHIAZOL-3(2H)-ONE (2682-20-4) Results of Endocrine Disruptor assessment Component Substance(s) not considered as endocrine disrupting. GLYCEROL(56-81-5), ETHANOL(64-17-5), 1,2-BENZISOTHIAZOL-3(2H)-ONE(2634-33- They are not included in the list established in 5), 2-METHYLISOTHIAZOL-3(2H)-ONE(2682-20-4) accordance with Article 59(1) of UK REACH for having endocrine disrupting properties, nor identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP

2.1 Classification of the substance or mixture

Classification according to GB CLP (SI 2019:720 as amended) Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction.